/Investor DB

Inkef — 2022 Investments

5 investments dated 2022 · listed companies and verified rows first · show all

Baserowbaserow.ioin𝕏Jul 2022

Baserow is an open-source low-code platform that allows users to build databases and applications without coding.

Cloud ComputingData & InfrastructureDeveloper ToolsSaaS

Bram Wiepjes(Founder)inOlivier Maes(Founder)

Co-investorsFrontline Venturesfirstminute capital

Happeohappeo.comin𝕏Jul 2022

Happeo is an intranet and enterprise search platform that integrates with Google Workspace and Microsoft 365, letting departments build no-code pages while IT retains security governance.

Enterprise SoftwareFuture of WorkSaaS

Co-investorsDN CapitalEndeit CapitalEvli Growth PartnersSmartFinVendep CapitalMaki.vc

PRECIRIX NVprecirix.comSeries B · Mar 2022 · $88M

Co-investorsBioMedPartnersHealthCapPontifax Venture CapitalV-Bio VenturesForbion

Remoteremote.comin𝕏May 2022

Remote helps companies hire, pay, and manage employees internationally by removing barriers to cross-border employment.

Future of WorkHR TechSaaSSan Francisco, US

Marcelo Lebre(Founder)inJob van der Voort(Founder)in

BoardVilli Iltchev(Director)Brett Rochkind(Director)Miles Clement(Director)Niko Bonatsos(Director)in

Co-investorsAccelB Capital GroupB4 CapitalBase PartnersCategory VenturesDaft Capital+15 more

TargED Biopharmaceuticalstargedbiopharmaceuticals.cominSeries A · Feb 2022 · $44M

TargED is a biopharmaceutical company developing therapeutics for thrombotic disorders, spun out from University Medical Center Utrecht.

BiotechMedical DevicesUtrecht, NL

Coen Maas(Co-founder)inSteven de Maat(Chief Scientific Officer)inMarc van Moorsel(Director of Operations)inKristof Vercruysse(Chief Executive Officer)inRob Dekker(Vice President CMC)inFilip Van den Wyngaert(Vice President Asset Management)in

Co-investorsAndera PartnersBioGeneration VenturesCurie CapitalFund+Hadean VenturesRotrip+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.